Cargando…
Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases
Macular degeneration is the leading cause of blindness in developed countries. In the treatment of neovascular age-related macular degeneration, vascular endothelial growth factor (VEGF) has emerged as a key target for therapy. The intravitreal injection of anti-VEGF drugs has been widely employed t...
Autores principales: | Ventrice, Pasquale, Leporini, Christian, Aloe, Jose’ Francisco, Greco, Ettore, Leuzzi, Giacomo, Marrazzo, Giuseppina, Scorcia, Giovanni Battista, Bruzzichesi, Donatella, Nicola, Varano, Scorcia, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853666/ https://www.ncbi.nlm.nih.gov/pubmed/24347979 http://dx.doi.org/10.4103/0976-500X.120947 |
Ejemplares similares
-
Endothelial connexins in vascular function
por: Hautefort, Aurélie, et al.
Publicado: (2019) -
False Myths versus Medical Facts: Ten Common Misconceptions Related to Dry Eye Disease
por: Giannaccare, Giuseppe, et al.
Publicado: (2020) -
Epigenetics and Common Ophthalmic Diseases
por: Li, Wendy, et al.
Publicado: (2016) -
Indian traditional medicinal plants in ophthalmic diseases
por: Nafees, Sana, et al.
Publicado: (2022) -
Endothelial cells on the move: dynamics in vascular morphogenesis and disease
por: Fonseca, Catarina G, et al.
Publicado: (2020)